賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體
Polyclonal Antibody to Lysyl Oxidase Like Protein 2 (LOXL2)
LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14
- 編號UPAF552Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPF552Mu01-賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 324 ¥ 756 ¥ 1080 ¥ 2700 ¥ 10800
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
IHC圖
-
Figure. Western Blot; Sample: Recombinant LOXL2, Mouse.
-
Figure. Western Blot; Sample: Lane1: Mouse Thymus Tissue.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對LOXL2的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別LOXL2。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPF552Mu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAF552Mu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 | WB |
| ULAF552Mu71 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| USEF552Mu | 賴氨酰氧化酶樣蛋白2(LOXL2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMF552Mu | 賴氨酰氧化酶樣蛋白2(LOXL2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603] |
| Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
| Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
| BMC Cancer | Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905] |
| Laryngoscope | Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623] |
留言咨詢
